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To the Editor:
Intraoperative, salvaged, autologous blood re-transfu-
sions are especially useful to treat profuse hemorrhage that
occurs during obstetric surgeries [1]. A prominent concern
with such autotransfusions is the risk that the relatively
large pore size (170–260 lm) of standard blood transfusion
filters may not eliminate all amniotic and fetal materials
and other contaminants from the salvaged, autologous
blood where they can cause amniotic fluid embolization
(AFE).
Use of leukocyte reduction filters (LRFs) with
10–50 lm pore size during salvage of autologous blood in
cesarean sections appears to be able to eliminate amniotic
and fetal particulate substances such as fetal squamous
cells [2], and thereby prevent AFE. Intraoperative auto-
transfusions with LRFs, therefore, represent a promising
technique for the treatment of profuse hemorrhage in
obstetric surgeries. However, since 2007, the Japanese Red
Cross Blood Center has provided pre-storage leukocyte-
reduced red cell concentrate containing a citrate–phos-
phate–dextrose solution instead of an acid–citrate–dextrose
solution as anticoagulant in which the leukocytes were
reduced soon after collection. LRFs have not been made
since 2006, and have not been supplied since 2009 by
Japanese manufacturers.
Microaggregate blood filters (MBFs) with 10–40 lm
pore size are able to eliminate larger-diameter, retained,
blood component microaggregate materials and non-blood,
particulate matter that is potentially harmful to the
recipients. In other words, MBFs assure the patient pro-
tection from microaggregate materials, clots, and particu-
late debris that can cause pulmonary embolization [3].
We managed a case with a re-transfusion of salvaged,
autologous blood using a Pall SQ40 (Pall, Tokyo, Japan)
MBF with 40 lm pore size instead of LRF for massive
hemorrhage during obstetric surgery [4]. Finally, abortion
and total abdominal hysterectomy were performed and no
AFE or other complications occurred.
The Pall SQ40 MBF is a free-flow, low priming vol-
ume device which provides a 40 lm rated filter and media
pleating for the elimination of potentially harmful blood
component microaggregates and non-blood component
particulate matter [5]. Pall’s 40 lm rated polyester screen
media is process-controlled and monitored to ensure uni-
formity of pore size to assure maximum patient protection
from microaggregates, clots, and particulate debris.
Further, screen-type MBFs are able to maintain a rel-
atively high speed of transfusion, because of their larger
total filter area. The total filter area of Pall’s screen-type
MBF (160 cm2) provides up to twelve times the typical
first surface area of a depth-type MBF. This feature
reduces the number of administration set changes required
for rapid transfusion, particularly for blood components
with a large debris load such as salvaged blood compo-
nents. In massive obstetric hemorrhage, rapid re-transfu-
sions are required for resuscitation. Since LRFs limit the
speed of transfusion, it is sometimes necessary to suspend
or forego the use of an LRF, and to use screen-type
MBFs, instead, in order to increase the speed of
transfusion.
In conclusion, MBFs instead of LRFs should be avail-
able and ready to use to purify salvaged, autologous blood
for re-transfusion to treat profuse hemorrhage during
obstetric surgeries, and to prevent AFE.
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